Euroopa Liit - eesti - EMA (European Medicines Agency)

theramex ireland limited - teriparatiid - osteoporoos - kaltsiumi homöostaas - livogiva is indicated in adults. osteoporoosi ravi postmenopausis naistel ja meestel, kellel on suurem luumurdude risk. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. ravi osteoporoosi seostatakse pidevat süsteemset glükokortikoidi ravi naiste ja meeste suurenenud risk luumurdude.

Euroopa Liit - eesti - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumokoki infektsioonid - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. vt lõigud 4. 4 ja 5. 1, mis käsitleb kaitset spetsiifiliste pneumokokkide serotüüpide eest. the use of vaxneuvance should be in accordance with official recommendations.

Euroopa Liit - eesti - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - prekursorko-lümfoblastne leukeemia-lümfoom - antineoplastilised ained - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

Euroopa Liit - eesti - EMA (European Medicines Agency)

santen oy - tsüklosporiin - sarvkestahaigus - oftalmoloogilised vahendid - raske keratiidi ravi kuiva silmahaigusega täiskasvanud patsientidel, mis ei paranenud hoolimata rebenemise asendajatest.

Euroopa Liit - eesti - EMA (European Medicines Agency)

santen oy - tsüklosporiin - conjunctivitis; keratitis - oftalmoloogilised vahendid - ravi raskeid kevadine keratoconjunctivitis (vkc) lastele alates 4 aasta vanusest ja noorukid.